| Heading: |
Medical Treatments |
| Question ID: |
1813041 |
| UIN: |
60245 |
| House: |
Commons |
| Date tabled: |
2025-06-16 |
| Asking Member ID: |
5149 |
| Asking Member display name: |
Amanda Hack
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Amanda Hack
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NHS trusts are prepared to deliver new therapies once they enter routine commissioning. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-25 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all new medicines, and significant licence extensions for existing medicines, should be routinely funded by the NHS in England ba... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |